← FDA DRUG APPROVALS

FDA ANDA · ANDA040407

PROCHLORPERAZINE

Sponsor: ABLE

APPLICATION
ANDA040407
TYPE
ANDA
ORIGINAL APPROVAL
2001-07-11
LATEST ACTION
2002-09-05
ROUTE
RECTAL
DOSAGE FORM
SUPPOSITORY
MARKETING STATUS
Discontinued

Products

PROCHLORPERAZINEDiscontinued
PROCHLORPERAZINE 5MG · SUPPOSITORY · RECTAL
PROCHLORPERAZINEDiscontinued
PROCHLORPERAZINE 25MG · SUPPOSITORY · RECTAL
PROCHLORPERAZINEDiscontinued
PROCHLORPERAZINE 2.5MG · SUPPOSITORY · RECTAL

Approval history

2002-09-05Labeling · Supplement 1AP
2001-07-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →